Egyptian International Pharmaceutical Industries Company (EGX:PHAR)
Egypt flag Egypt · Delayed Price · Currency is EGP
50.11
-0.59 (-1.16%)
At close: Jun 4, 2025

EGX:PHAR Income Statement

Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
8,3877,5915,2323,9553,4092,886
Upgrade
Revenue Growth (YoY)
46.06%45.09%32.27%16.03%18.13%-15.40%
Upgrade
Cost of Revenue
4,6544,2442,9832,3971,9571,675
Upgrade
Gross Profit
3,7333,3462,2481,5581,4521,211
Upgrade
Selling, General & Admin
1,0961,065788.09683.2566.08547.58
Upgrade
Research & Development
64.6870.4543.2343.6834.9620.87
Upgrade
Other Operating Expenses
323.67378.57167.2134.3560.7955.35
Upgrade
Operating Expenses
1,7901,8441,038896.23674.83623.8
Upgrade
Operating Income
1,9441,5031,211662776.85587.32
Upgrade
Interest Expense
-1,124-928.54-388.52-195.42-136.25-83.16
Upgrade
Interest & Investment Income
105.772.0526.2457.7732.1140.57
Upgrade
Earnings From Equity Investments
151.58151.5874.51--37.18
Upgrade
Currency Exchange Gain (Loss)
157.21699.88139.63286.4-6.25-11.55
Upgrade
Other Non Operating Income (Expenses)
20.0411.041.51-20.62-24.0413.37
Upgrade
EBT Excluding Unusual Items
1,2541,5091,064790.13642.41583.74
Upgrade
Gain (Loss) on Sale of Assets
0.90.224.693.72.783.8
Upgrade
Pretax Income
1,2551,5091,069793.83645.19587.55
Upgrade
Income Tax Expense
443.16411.83245.62150.07156.9100.15
Upgrade
Earnings From Continuing Operations
812.041,097823.31643.76488.29487.4
Upgrade
Minority Interest in Earnings
-1.1-1.21-0.99-0.78-0.53-0.89
Upgrade
Net Income
810.951,096822.32642.98487.75486.51
Upgrade
Net Income to Common
810.951,096822.32642.98487.75486.51
Upgrade
Net Income Growth
-34.46%33.25%27.89%31.83%0.25%-27.45%
Upgrade
Shares Outstanding (Basic)
149149149999998
Upgrade
Shares Outstanding (Diluted)
149149149999998
Upgrade
Shares Change (YoY)
--50.00%-1.64%-1.61%
Upgrade
EPS (Basic)
5.457.375.536.484.924.99
Upgrade
EPS (Diluted)
5.457.375.536.484.924.99
Upgrade
EPS Growth
-34.46%33.25%-14.74%31.83%-1.36%-26.26%
Upgrade
Free Cash Flow
-1,894-4,121-2,198-859.77-53.27-38.7
Upgrade
Free Cash Flow Per Share
-12.73-27.70-14.77-8.67-0.54-0.40
Upgrade
Dividend Per Share
1.5001.5001.0001.0001.500-
Upgrade
Dividend Growth
50.00%50.00%--33.33%--
Upgrade
Gross Margin
44.51%44.09%42.98%39.40%42.59%41.97%
Upgrade
Operating Margin
23.18%19.79%23.14%16.74%22.79%20.35%
Upgrade
Profit Margin
9.67%14.44%15.72%16.26%14.31%16.86%
Upgrade
Free Cash Flow Margin
-22.58%-54.29%-42.01%-21.74%-1.56%-1.34%
Upgrade
EBITDA
2,0401,5991,314759.39867.73726.89
Upgrade
EBITDA Margin
24.32%21.07%25.12%19.20%25.46%25.19%
Upgrade
D&A For EBITDA
96.2496.53103.1797.3990.88139.57
Upgrade
EBIT
1,9441,5031,211662776.85587.32
Upgrade
EBIT Margin
23.18%19.79%23.14%16.74%22.79%20.35%
Upgrade
Effective Tax Rate
35.31%27.30%22.98%18.90%24.32%17.04%
Upgrade
Updated Mar 2, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.